» Articles » PMID: 35731658

A Challenge to Respiratory Syncytial Virus Illness in Adults

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2022 Jun 22
PMID 35731658
Authors
Affiliations
Soon will be listed here.
Citing Articles

Nirsevimab brings breakthrough in the prevention of respiratory syncytial virus infection in infants - Importance of design.

Zhaori G Pediatr Investig. 2023; 7(2):144-146.

PMID: 37324599 PMC: 10262870. DOI: 10.1002/ped4.12377.


The anti-inflammatory and antiviral properties of anionic pulmonary surfactant phospholipids.

Numata M, Kandasamy P, Voelker D Immunol Rev. 2023; 317(1):166-186.

PMID: 37144896 PMC: 10524216. DOI: 10.1111/imr.13207.